en News - BIOINFORMATICS BARCELONA News Fri, 03 Dec 2021 09:34:34 +0000 Fri, 03 Dec 2021 09:34:34 +0000 Houdini 2 (https://houdini.antaviana.cat/) https://www.bioinformaticsbarcelona.eu/news BIB presents the Companies Catalogue 2021

Bioinformatics Barcelona (BIB) presents the 2021 edition of its Companies Catalogue.

Made in collaboration with all BIB member companies, the catalogue aims to jointly show the range of business activities and services offered by all these companies that are part of the institution.

This digital document contains a wide variety of information, from the description of each company to its milestones and keywords related to its activities.

You can download the Companies Catalogue 2021 below:

]]>
Fri, 03 Dec 2021 09:34:34 +0000 https://www.bioinformaticsbarcelona.eu/news//news/207/bib-presents-the-companies-catalogue-2021 https://www.bioinformaticsbarcelona.eu/news/207 0
EMBO presents its survey to know the needs of the life sciences community

The European Molecular Biology Organization (EMBO) is a not-for-profit organization established in 1964 with the mission to promote excellence in the life sciences in Europe and beyond.

The survey's objective is to learn whether EMBO is doing for the research community what that community needs most, and how EMBO is perceived in general and in comparison to other, similar institutions. Both EMBO Council and EMBC have discussed the value of EMBO's programmes and activities in their meetings over the last two years, and this survey follows up on questions raised in these meetings.

They survey can be filled here  before December 17th

]]>
Wed, 01 Dec 2021 09:28:37 +0000 https://www.bioinformaticsbarcelona.eu/news//news/205/embo-presents-its-survey-to-know-the-needs-of-the-life-sciences-community https://www.bioinformaticsbarcelona.eu/news/205 0
Mediktor joins the Bioinformatics Barcelona ecosystem

Bioinformatics Barcelona adds a new member to its ecosystem: the company Mediktor

Mediktor has developed a medical assistant that is based on Artificial Intelligence (AI). Its technology identifies patient's symptoms using natural language recognition, allowing the interpretation of more than one symptom at the same time. In the conversation with the medical assistant the questions require only simple responses and are supported by further explanations and images to create an optimal user experience. The result is a recommendation related to the urgency level of the provided symptoms and a list of possible diseases the patients could be suffering from, guiding them to the right level of care at the right time. The company's software was clinically validated with a success rate of up to 91.3% in trials with real patients.

Mediktor operates a B2B model, as the company offers a SaaS white label solution working for insurance companies, hospitals, telemedicine platforms and pharma companies. With offices in Barcelona and New York, Mediktor plans to expand the use of their AI solution around USA, Europe, and Latin America.

You can know more about them by clicking here.

]]>
Wed, 24 Nov 2021 09:22:47 +0000 https://www.bioinformaticsbarcelona.eu/news//news/203/mediktor-joins-the-bioinformatics-barcelona-ecosystem https://www.bioinformaticsbarcelona.eu/news/203 0
IMIDomics joins the Bioinformatics Barcelona ecosystem

Bioinformatics Barcelona adds a new member to its ecosystem: IMIDomics

IMIDomics is a biotechnological company identifying more specific and more efficacious drugs for patients suffering from immune-mediated inflammatory diseases (IMIDs).  We are leveraging multiple technological approaches and large collections of well-defined patients. The company's mission is to accelerate new target identification and validation for a diverse group of IMIDs including the musculoskeletal, skin and gastrointestinal therapeutic areas. Our R&D team is located in Barcelona.

You can know more about them by clicking here.

]]>
Thu, 18 Nov 2021 10:41:29 +0000 https://www.bioinformaticsbarcelona.eu/news//news/201/imidomics-joins-the-bioinformatics-barcelona-ecosystem https://www.bioinformaticsbarcelona.eu/news/201 0
CRAG researchers develop an algorithm to measure fruit morphology

Researchers from the Centre for Research in Agricultural Genomics (CRAG), BIB MEMBER, have developed an automatized and cost-effective computing method to evaluate fruit shape and colour that will contribute to increasing agriculture efficiency.

This work applies deep learning techniques to evaluate fruit shapes. Combining such methods with linear and multivariate measurements, researchers were able to generate an automatized software pipeline that analyses shape and colour patterns extracted from strawberry images.

This contribution can be very valuable in the first step of breeding programmes, since it would allow evaluating various crosses without the need to test them directly in the field, saving time and resources.

]]>
Fri, 02 Jul 2021 12:26:15 +0000 https://www.bioinformaticsbarcelona.eu/news//news/199/crag-researchers-develop-an-algorithm-to-measure-fruit-morphology https://www.bioinformaticsbarcelona.eu/news/199 0
20% book reservation for BIB Members on the R and Deep Learning courses

Improve your knowledge about R and deep learning with the courses that Universitat de Barcelona (UB), Bioinformatics Barcelona member (BIB), is offering for this June, July, and September 2021. These courses count with a 20% book reservation for BIB members. 

Organized by the Department of Genetics, Microbiology, and Statistics of the Faculty of Biology and under the coordination of Dr. Francesc Carmona, the courses do not require prerequisites to access them and are recognized with a university extension certificate.

Due to the exceptional situation caused by the pandemic, the courses will be taught through the virtual sessions. Read more about the courses and registration in the document attached below.

]]>
Tue, 08 Jun 2021 13:03:40 +0000 https://www.bioinformaticsbarcelona.eu/news//news/197/20-book-reservation-for-bib-members-on-the-r-and-deep-learning-courses https://www.bioinformaticsbarcelona.eu/news/197 0
Sequentia Biotech has collaborated in the development of a new COVID-19 vaccine

The company Sequentia Biotech, BIB MEMBER, has collaborated in the development of a new COVID-19 vaccine.
The new vaccine is similar to others already authorized because it stimulates the immune response against the Spike protein that the Coronavirus uses to infect cells.  It also presents some substantial differences like the use of a probiotic bacterium as a vector, the oral administration, and, so far, no side effects.
The preclinical data conducted, with the participation of Sequentia Biotech, shows that the administration of engineered Escherichia Coli Nissle 1917 was able to significantly stimulate the immune response with the production of circulating IgM and IgG antibodies without any adverse effects being documented.

]]>
Thu, 03 Jun 2021 07:43:06 +0000 https://www.bioinformaticsbarcelona.eu/news//news/195/sequentia-biotech-has-collaborated-in-the-development-of-a-new-covid-19-vaccine https://www.bioinformaticsbarcelona.eu/news/195 0
ALBA offers internships for university students

ALBA SYNCHROTRON, Bioinformatics Barcelona (BIB) member, is offering internships on Bioinformatics for the academic year 21-22 in different branches of the facilities. Students who are interested must apply before 31st May 2021. The proposed internships in Bioinformatics are:

  1. Electron beam simulations from a thermionic RF-gun

  2. System for measurement superconductive materials at microwave frequencies for CERN's Future Circular Collider

You can check the information on the proposed internships and how to apply at this link.

]]>
Thu, 06 May 2021 12:04:44 +0000 https://www.bioinformaticsbarcelona.eu/news//news/193/alba-offers-internships-for-university-students https://www.bioinformaticsbarcelona.eu/news/193 0
Bioinformatics involved in identifying a potential target to treat lung cancer at IRB Barcelona

Researchers at IRB Barcelona, a BIB member, have discovered that the HMCES enzyme is very effective against lung tumours with a higher number of mutations caused by the APOBEC system (an antiviral defence mechanism). 

The study, led by Dr Travis Stracker and Dr Fran Supek, comprises both computational and experimental approaches and is the result of the collaboration between two research groups working on different disciplines. Genetic screening experiments were performed using CRISPR/Cas9 on several types of human lung adenocarcinoma cell lines.

Personalised medicine takes advantage of the unique genetic changes in an individual tumour to find its vulnerabilities and fight it. However, the APOBEC system can accidentally damage DNA and cause a higher number of mutations in the tumour.

In this context, IRB Barcelona is organizing The Metastasis Challenge to raise money in support of the research into metastasis.

More info about this study here.

]]>
Thu, 06 May 2021 12:04:16 +0000 https://www.bioinformaticsbarcelona.eu/news//news/191/bioinformatics-involved-in-identifying-a-potential-target-to-treat-lung-cancer-at-irb-barcelona https://www.bioinformaticsbarcelona.eu/news/191 0
The BIB's Toolkit on ethics for the bioinformatics is now available at BIB's website

The BIB's Toolkit on ethics for the bioinformatics "Toolkit para la formación en ética de la bioinformática" is now available on BIB's website. 

This book offers a compilation of tools, theories, and data intended to help to teach professionals through the task of programming an introductory course to ethics in bioinformatics.

This Toolkit is the result of the combined work of the Ethics and Data Security Group, a multidisciplinary team of Bioinformatics Barcelona constituted in order to provide and share knowledge as well as workflow tools to all bioinformatics professionals who use sensible data.

You can access this tool for free through this link.

]]>
Mon, 26 Apr 2021 09:03:06 +0000 https://www.bioinformaticsbarcelona.eu/news//news/189/the-bib-s-toolkit-on-ethics-for-the-bioinformatics-is-now-available-at-bib-s-website https://www.bioinformaticsbarcelona.eu/news/189 0